Renaissance Technologies LLC Cuts Position in Addus HomeCare Co. (NASDAQ:ADUS)

Renaissance Technologies LLC reduced its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 10.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 109,700 shares of the company's stock after selling 13,000 shares during the period. Renaissance Technologies LLC owned approximately 0.61% of Addus HomeCare worth $13,751,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of ADUS. Smartleaf Asset Management LLC increased its position in shares of Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares in the last quarter. Parkside Financial Bank & Trust increased its position in Addus HomeCare by 38.6% during the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares during the last quarter. Meeder Asset Management Inc. bought a new position in Addus HomeCare in the fourth quarter valued at about $77,000. Harvest Fund Management Co. Ltd purchased a new position in Addus HomeCare in the fourth quarter worth about $86,000. Finally, KBC Group NV grew its stake in shares of Addus HomeCare by 49.1% during the 4th quarter. KBC Group NV now owns 814 shares of the company's stock valued at $102,000 after purchasing an additional 268 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ADUS. Oppenheimer increased their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Macquarie reaffirmed an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research note on Thursday, February 27th. JMP Securities reissued a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Thursday, April 10th. Stephens reaffirmed an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Finally, StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $132.78.

Addus HomeCare Trading Up 0.2 %

Addus HomeCare stock traded up $0.25 during trading on Friday, hitting $101.25. The company had a trading volume of 155,273 shares, compared to its average volume of 164,791. Addus HomeCare Co. has a 1-year low of $87.88 and a 1-year high of $136.72. The company's 50 day simple moving average is $99.45 and its 200-day simple moving average is $116.98. The stock has a market cap of $1.84 billion, a price-to-earnings ratio of 23.17, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.